DiscGenics Collaboration Successfully Develops Allogeneic Therapy to Enable Efficient Manufacturing
DiscGenics is a biopharmaceutical company that develops regenerative cell-based…
Process Development
Collaborative Relationship Allows Avectas to Accelerate the Translation of SOLUPORE Into the Clinic
Avectas is an Ireland-based cell engineering technology company developing a unique intracellular delivery platform to enable ex vivo cell-based therapies.
The Cystic Fibrosis (CF) Canada Program in Individualized Therapy (CFIT)
Establishing a bank of 100 patient-derived iPSC lines and isogenic controls…
Process Development for Scaled-Up hESC/hiPSC Manufacturing
An optimized 14-day manufacturing workflow developed in < 12 months...
Animal Component Free (ACF) Media Development for Cell Therapies
ACF media achieved comparable performance to serum containing…